Yashraj Rajani, Cfa
About Yashraj Rajani, Cfa
Yashraj Rajani is an Equity Research Associate Director at UBS in London, England, with a focus on ESG investing and experience in various sectors including consumer and healthcare. He has a strong background in equity research, having worked in both buy-side and sell-side roles across European and Indian markets.
Work at UBS
Yashraj Rajani currently holds the position of Equity Research Associate Director at UBS, where he has been employed since 2023. In this role, he focuses on equity research, particularly covering the apparel retail sector. Prior to this position, he served as an Equity Research Analyst at UBS from 2021 to 2023, also based in London. His experience at UBS has contributed to his expertise in analyzing market trends and financial performance within various sectors.
Education and Expertise
Yashraj Rajani completed his Bachelor of Commerce (B.Com.) at H.R. College of Commerce and Economics from 2011 to 2016. He furthered his education by obtaining a Master of Science (M.Sc.) in Finance and Financial Management Services from ESSEC Business School, graduating in 2019. His academic background is complemented by his expertise in ESG (Environmental, Social, and Governance) investing, which is a critical area in modern finance.
Background
Yashraj Rajani began his career in finance with various internships, including a role as an Intern - Equity Research Analyst at Reliance Capital from 2017 to 2018 in Mumbai. He also interned at Rothschild & Co as a Buy-Side Analyst in 2019 in Paris, and at BlackRock as an Intern - Equity Research Analyst in 2017. His early experiences laid the foundation for his subsequent roles in equity research and investor relations across multiple countries.
Achievements
Throughout his career, Yashraj Rajani has developed a diverse skill set through various roles in equity research and analysis. He has worked on both the buy-side and sell-side in the European and Indian markets, gaining sector experience in Consumer, FIG (Financial Institutions Group), Healthcare, and Life Sciences. His contributions in these areas have enhanced his understanding of market dynamics and investment strategies.